CORONA
CORONA REMEDIES LIMITEDHealthcare
LTP
2,058.8
CHG · %
+13.3 (+0.65%)
VOL · TODAY
23.27K
PREV CLOSE
2,045.5
Today's range2,045.2 · 2,089.6
2,058.8
52-week range1,336.6 · 2,270.1
2,058.8
Loading candles…
Corona Remedies Limited, incorporated in August 2004, is an Indian pharmaceutical company engaged in developing, manufacturing, and marketing pharmaceutical products. The company focuses on domestic formulations primarily in therapeutic areas including women’s healthcare, cardiology, pain management, urology, and chronic healthcare. Its business segments reflect these key healthcare domains, with an emphasis on the chronic and women’s healthcare markets. Corona Remedies has undertaken organic brand building and strategic acquisitions of brands and portfolios from global pharmaceutical companies. The company operates within the pharmaceutical industry in India but does not have any listed subsidiaries or public exchange listings reported.
CORONA is not part of any active scan today.
This page is a live market overview for CORONA REMEDIES LIMITED (CORONA) on the NSE. As a listed security, CORONA REMEDIES LIMITED is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for CORONA before placing trades on tick2trade.
As of the latest feed, CORONA last traded at ₹2,058.8 on NSE, up ₹13.3 (0.65%) from the previous close of ₹2,045.5. Today's session range is ₹2,045.2 – ₹2,089.6, against a 52-week band of ₹1,336.6 – ₹2,270.1. Traded volume today stands at 23.27K shares.
The overview consolidates an interactive price chart with multiple time ranges, recent market headlines, upcoming corporate events for CORONA in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether CORONA is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for CORONA REMEDIES LIMITED before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in CORONA. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated CORONA option chain page linked from this overview.
// similar in healthcare314 total